Doctor Reports Cancer Cases Linked to COVID-19 Vaccination: What We Know So Far

Infectious Disease Specialist Raises Concerns

According to Главком: Dr. Lyubov Kotsyubailo, an infectious disease specialist, has voiced concerns over cancer cases that may be connected to COVID-19 vaccination. According to her, advanced laboratories in Germany, Israel, the United States, and Japan are detecting new instances of cancer, identified through biopsies and immunohistochemistry. Scientific findings suggest these pathologies could be linked to post-vaccination effects.

Kotsyubailo emphasized that these novel cancer types often resist standard treatments, adding to the worry. She also noted that data on such cases are documented in specialized scientific publications.

“It has been well-established that new oncological diseases have emerged... They write that this cancer is associated with the COVID-19 vaccine. You see, these are things that exist in the scientific world, they are known, and everyone is paying attention to them,” the doctor stated.

Growing Caution Around Vaccination

It is worth noting that many countries are currently halting booster vaccination campaigns, which may reflect increasing caution over potential side effects.

“This is being studied at a high level now, but the fact is that you can get a peculiar form of cancer that later does not respond well to treatment. Such cases already exist in the world,” Kotsyubailo added.

Mass vaccination against COVID-19 began globally in 2021. In Ukraine, a subvariant of the Omicron coronavirus lineage, named 'Cicada,' has also been detected. According to the World Health Organization (WHO), the 'Cicada' subvariant shows no signs of being able to trigger a new major wave of infections.

The concerns raised by Dr. Kotsyubailo highlight the ongoing debate about potential vaccination consequences, which remains a focus of active scientific research. The need to further investigate the link between vaccination and new cancer forms could influence global vaccination strategies, particularly decisions on booster doses. This situation underscores the importance of a balanced approach to vaccination and continuous monitoring of its health impacts.